Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Samsara Biocapital, Llc
Form 13F · Q2 2026

Samsara Biocapital, Llc

CIK 1744967申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$12.2亿
申报组合市值
24
持仓数量
12
Quarters on record
Top 50
持仓数量

Samsara Biocapital, Llc——持仓

共 24 个持仓中的前 24 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1SRRK Scholar Rock Hldg Corp6.9M+0.0%$3.8亿31.2%
2ALMS Alumis Inc6.3M+0.0%$1.8亿14.7%
3MLYS Mineralys Therapeutics Inc5.9M+0.0%$1.6亿13.0%
4SEPN Septerna Inc3.1M+0.0%$1.1亿8.7%
5ALMR Alamar Biosciences Inc2.5M—$6719万5.5%
6NGNE Neurogene Inc1.7M+0.0%$5400万4.4%
7KLRS Kalaris Therapeutics Inc12.9M−0.5%$5243万4.3%
8SGP Spyglass Pharma Inc2.1M+0.0%$4697万3.9%
9STRO Sutro Biopharma Inc1.1M+0.0%$3529万2.9%
10IVA Inventiva Sa6.3M+21.6%$2387万2.0%
11JBIO Jade Biosciences Inc736,237−24.0%$1636万1.3%
12PBLS Parabilis Medicines Inc556,044—$1522万1.3%
13VTVT Vtv Therapeutics Inc298,496+0.0%$1124万0.9%
14AQST Aquestive Therapeutics Inc2.5M+0.0%$1040万0.9%
15NKTX Nkarta Inc3.5M+0.0%$993万0.8%
16ARTV Artiva Biotherapeutics Inc954,861—$926万0.8%
17RANI Rani Therapeutics Hldgs Inc10.4M+22.0%$788万0.6%
18AGMB Agomab Therapeutics Nv600,000+0.0%$779万0.6%
19ABVX Abivax Sa55,095−2.6%$734万0.6%
20XFOR X4 Pharmaceuticals Inc1.4M−23.8%$652万0.5%
21ELOX Eloxx Pharmaceuticals Inc400,000—$555万0.5%
22CHRS Coherus Oncology Inc3.4M+0.0%$480万0.4%
23UPB Upstream Bio Inc353,717−51.9%$245万0.2%
24GOSS Gossamer Bio Inc7.2M+0.0%$119万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。